A $275 million settlement announced in February 2025 resolves a decade-long antitrust lawsuit against Sandoz Inc. and Fougera Pharmaceuticals for conspiring to fix prices on approximately 165 generic drugs.
If you purchased or paid for any of these generic medications between May 2009 and December 2019—either as a consumer, insurance company, or health plan—you may be eligible to claim compensation from this class action settlement. The settlement addresses allegations that generic drug manufacturers violated federal antitrust laws by allocating customers, rigging bids, and artificially inflating prices, practices that affected healthcare costs for millions of Americans and their payers.
Table of Contents
- What Was the Generic Pharmaceuticals Price-Fixing Conspiracy?
- Who Is Eligible to File a Claim in This Settlement?
- How Much Money Is in the Settlement Fund and How Will It Be Distributed?
- What Are the Important Dates and Deadlines for Filing a Claim?
- What Specific Drugs Are Covered Under the Settlement?
- How Does This Settlement Relate to Other Generic Drug Price-Fixing Cases?
- What Should You Do Now to Prepare Your Claim?
What Was the Generic Pharmaceuticals Price-Fixing Conspiracy?
Between May 2009 and December 2019, according to court filings in the Eastern District of Pennsylvania, Sandoz and Fougera Pharmaceuticals allegedly conspired with other generic drug manufacturers to violate antitrust law. The scheme involved multiple anti-competitive practices: manufacturers allegedly allocated specific customer accounts to each other to avoid direct competition, rigged bids to ensure pre-determined winners, and coordinated price increases to artificially inflate what end-payers (consumers, insurance companies, and health plans) would have to pay. This wasn’t limited to a single drug or a few months—the conspiracy allegedly spanned approximately 165 different generic medications over an eleven-year period. The impact was broad and persistent. When generic drug manufacturers coordinate prices, the effect cascades through the entire healthcare system. Insurance companies pay more for medications, which means higher premiums for consumers and increased out-of-pocket costs at the pharmacy. Government programs like Medicare and Medicaid pay inflated prices, which affects taxpayers.
Small employers and large ones alike saw their pharmacy benefit costs rise due to artificially high generic drug prices. Sandoz has neither admitted nor denied the allegations as part of this settlement, but agreed to pay $275 million to resolve the claims. The case, filed as In re Generic Pharmaceuticals Antitrust Litigation (No. 16-MD-2724), has been ongoing in federal court for nearly a decade. Judge Cynthia M. Rufe has overseen the litigation, which consolidated claims from consumers and third-party payers across the country. The preliminary approval of the settlement came on February 19, 2025, opening the door for affected parties to begin filing claims.
Who Is Eligible to File a Claim in This Settlement?
The settlement defines two broad categories of eligible claimants: consumers and third-party payers. Consumers include any individual who paid out-of-pocket (through deductibles, co-pays, or full retail price) for any of the 165 covered generic drugs during the conspiracy period. Third-party payers include health insurance companies, health maintenance organizations (HMOs), workers’ compensation programs, government health programs, pharmacy benefit managers, and any other entity that paid for these drugs on behalf of individuals. However, if you lived in Indiana or Ohio, you are not eligible—the settlement excludes these two states due to specific legal reasons related to how the lawsuit proceeded. Geographic coverage includes all 50 states (except Indiana and Ohio), the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.
This is where it becomes important to verify: the settlement does not cover residents of Indiana and Ohio, even if they purchased the drugs in another state or if they moved after the drugs were purchased. If you’re in either of those states, you may still have other legal options depending on whether separate class actions or individual claims apply to you—but you cannot claim from this specific $275 million settlement. If you’re in any other U.S. jurisdiction and received or paid for the covered drugs during the May 2009 to December 2019 period, you should carefully review the claim documentation to determine if you meet the eligibility requirements. One important limitation: you must have actually purchased or paid for the drugs—simply having them prescribed doesn’t entitle you to a claim if someone else (like a government program with a separate claim) already paid for them. However, if you paid a copay on top of what insurance covered, you likely have a claim for that copay amount.
How Much Money Is in the Settlement Fund and How Will It Be Distributed?
The gross settlement amount is $275 million, but not all of that money goes directly to claimants. Before any payments to individuals or third-party payers are made, several deductions come from the fund. Administrative costs for notifying the class, processing claims, and managing the settlement administrator can be up to $750,000. Litigation expenses—the costs incurred by the plaintiffs’ lawyers to investigate and litigate the case over the past decade—can total up to $26 million. Attorneys’ fees, subject to court approval, can be up to one-third of the remaining fund plus accrued interest, which is a standard arrangement in class action settlements but significantly reduces what’s available for claimants. The settlement also provides for service awards up to $500,000 total to be distributed among the named Settlement Class Representatives—the individuals whose names appear on the lawsuit and who took on the responsibility of representing the broader class.
These payments compensate them for their time, effort, and the publicity they endured throughout the litigation. After all these deductions, the remaining amount is distributed to claimants based on claims submitted. The exact amount each claimant receives depends on how many claims are filed and how much each claimant actually spent on the covered drugs. This is a “claims-made” settlement, meaning you must actively submit a claim to receive compensation; money is not automatically paid out. The settlement was subject to preliminary approval on February 19, 2025, and a final approval hearing was scheduled for July 23, 2025. Until the final approval hearing concludes, the exact payout amounts remain uncertain, though the fund amount itself is fixed at $275 million.
What Are the Important Dates and Deadlines for Filing a Claim?
The timeline for this settlement spans several months and includes critical deadlines you must not miss. After the preliminary approval in February 2025, the settlement administrator mailed notice to eligible class members. The deadline to submit a claim (the “Claim Deadline”) is typically 60 to 90 days from when the notice was sent, though you should verify the exact deadline by visiting the official settlement website or reviewing the notice you received. Missing this deadline means forfeiting your right to claim any money from the settlement—there are generally no exceptions for missed deadlines. The final approval hearing is scheduled for July 23, 2025, where the judge will decide whether to formally approve the settlement. At that hearing, the court will also consider the attorneys’ fees request, the administrative costs, and the service awards to class representatives.
If the judge approves everything, then claim processing begins and payments are distributed. If the judge rejects or significantly modifies the settlement, the timeline would be delayed. After final approval, claimants can typically expect to receive settlement payments within 60 to 120 days, depending on how quickly claims are processed. However, if there are appeals or further legal challenges, the timeline could extend. The takeaway: mark your claim deadline on your calendar and submit your claim well before it expires. Once that date passes, you cannot recover any compensation, no matter the circumstances.
What Specific Drugs Are Covered Under the Settlement?
The settlement covers approximately 165 generic pharmaceutical drugs that were allegedly subject to the price-fixing conspiracy. The drugs span multiple therapeutic categories, including common medications for treating infections, chronic conditions, and other health issues. Rather than listing all 165 drug names, which would be unwieldy, the settlement defines covered drugs by reference to the litigation record and provides a detailed list on the official settlement website. The challenge for claimants is that you need to know whether the specific drug you purchased was actually one of the 165 covered drugs.
If you kept pharmacy receipts or prescription documentation from between May 2009 and December 2019, those records will show the exact drug name and generic manufacturer. You can then cross-reference that information against the complete list of covered drugs available on the settlement website. If you don’t have detailed records, the settlement website allows you to search by drug name or generic manufacturer to see if your medication was included. However, if you cannot determine which drugs you purchased, you face a practical barrier to claiming—you cannot claim compensation without demonstrating that you purchased a covered drug. Keep in mind that brand-name drugs are not covered; only the generic versions of these medications are included in the conspiracy.
How Does This Settlement Relate to Other Generic Drug Price-Fixing Cases?
The Sandoz and Fougera settlement is not an isolated case. In February 2026, less than a year after this settlement was announced, 48 states and territories announced separate antitrust settlements with other generic drug manufacturers: Lannett Company Inc. agreed to pay $13.77 million and Bausch Health agreed to pay $4.08 million for their alleged roles in related price-fixing conspiracies.
These settlements indicate that the generic drug price-fixing problem was broader than just Sandoz and Fougera—multiple manufacturers were investigated and found liable for similar anti-competitive conduct. If you purchased drugs from manufacturers other than Sandoz and Fougera, you may be eligible for separate claims against Lannett, Bausch Health, or other defendants who have settled or may settle in the future. The claims process is typically separate for each settlement, and you would need to file claims in each relevant settlement based on the specific drugs you purchased from each manufacturer. This means if you bought a generic antibiotic from Sandoz and a generic diabetes medication from Lannett, both between 2009 and 2019, you could potentially claim from both settlements—but you would need to file separate claims with documentation for each.
What Should You Do Now to Prepare Your Claim?
To successfully claim from this settlement, start by gathering documentation of your purchases. If you have pharmacy receipts, insurance explanation of benefits (EOBs), or prescription records from between May 2009 and December 2019, collect these in one place. Your documentation should ideally show the generic drug name, the date of purchase or prescription fill, and the amount you paid. If the settlement allows claims based on insurance records (as many do), you may be able to submit a claim even without personal pharmacy receipts by providing your insurance information and letting the settlement administrator verify your purchases through the insurance company’s records.
Visit the official settlement website at genericdrugsendpayorsettlement.com to review the complete list of covered drugs, understand the specific claim procedures, and locate the claim form. You can submit claims online, by mail, or through other methods specified by the settlement administrator. Do not wait until the deadline approaches—submit your claim as early as possible to avoid last-minute issues or missing the deadline. Once you file your claim, the settlement administrator will review it, verify your eligibility and the amount you paid for covered drugs, and then process payment. Keep copies of everything you submit and note your claim number for future reference.